MELBOURNE, Australia: Amplia Therapeutics Limited (ASX: ATX), a company developing new drug candidates for the treatment for cancer and fibrosis, announced the appointment of Christopher Burns Ph.D. as Chief Executive Officer, and Managing Director starting Dec 5th 2022. Dr Burns is a founder of Amplia and has served as a non-executive member of the Board…